Predictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate

Background and study aim: The current standard of care (SOC) for chronic hepatitis C (CHC) in Egypt is pegylated interferon and ribavirin (PEG-INF/RBV) for 48 weeks, which is expensive, can be difficult to tolerate and with high failure rate. Additional information about predicting sustained virolog...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sahar El-Nemr, Hala Hussein, Monkez Yousif, Mohamed Abdel-Aal, Hoda El-Hady
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department 2012-03-01
Ráidu:	Afro-Egyptian Journal of Infectious and Endemic Diseases
Fáttát:	HCV PEGINF response predictors Ribavirin Pegylated interferon-α
Liŋkkat:	https://aeji.journals.ekb.eg/article_15415_42bdc9b8194658d83a9006087abfc96b.pdf
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!